-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Ignasi Rodriguez-Pinto, Gerard Espinosa1 & Ricard Cervera
Drug Evaluation: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
World Vaccine Trials Congress 2012
Jonathan K Fallon,James L Gulley
Conference Report: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation